2Legro RS. Polycystic ovary syndrome. Long term sequelae and management[J]. Minerva Ginecol,2002,54(2):97-114.
3Matthews DR,Hosker JP, Rudenski AS, et al.Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man[J]. Diabetologia, 1985, 28(7):412-419.
4Franks S. Polycystic ovary syndrome[J]. N Engl J Med, 1995,333( 13 ):853-861.
5Legro RS, Driscoll D, Strauss JF, et al. Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome [J].Proc Natl Acad Sci USA, 1998, 95(25):14956-14960.
6Venkatesan AM,Dunaif A,Corbould A.Insulin resistance in polycystic ovary syndrome:progress and paradoxes [J].Recent Prog Horm Res, 2001,56,295-308.
7Dunaif A. Insulin Resistance and the Polycystic Ovary Syndrome:Mechanism and Implications for Pathogenesis [J]. Endocrine Reviews, 1997, 18(6): 774-800.
8Falsetti L, Pasinetti R. Effects of long term administration of an orai contraceptive containing ethinyl estradiol and cyproterone acetate on lipid metabolism in women with PCOS [J].Acta Obstet Gynecol Scand, 1995,74(1 ):56-60.
